AKT1 and hepatocellular carcinoma: Similarly, in later years, it was demonstrated that in hepatocellular carcinoma (HCC), AChE activated the STAT3 and AKT pathways by interacting with the androgen receptor (AR), enhancing the migration and invasion of HCC cells while inhibiting their apoptosis (Nie et al., 2013).